Skip to main content
SpringerLink
Log in

Eosinophilic Gastroenteritis

Epidemiology, Diagnosis and Management

  • Therapy In Practice
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Eosinophilic gastroenteritis is a heterogeneous and uncommon disorder characterized by eosinophilic inflammation of the gastrointestinal tissues. The location and depth of infiltration determine its varied manifestations, and the latter is also the basis for the proposed classification into mucosal, muscular and serosal eosinophilic gastroenteritis. Abdominal pain, vomiting, and diarrhea are each present in nearly 50% of the patients, with some overlap. Peripheral eosinophilia is seen in approximately two-thirds of patients with eosinophilic gastroenteritis.

It is now clear that eotaxin, a specific eosinophil chemoattractant, plays a pivotal role in the process of eosinophil production. The differential diagnosis of eosinophilic gastroenteritis in children includes parasitic infections, inflammatory bowel disease, connective tissue diseases, some malignancies and adverse effects of drugs.

Eosinophilic gastroenteritis itself has been strongly associated with food allergies, and concomitant atopic diseases or a family history of allergies is elicited in about 70% of cases. The pediatric experience is unique with respect to recognition of distinctive entities such as allergic procto-colitis, almost exclusively seen in infants, and eosinophilic esophagitis being increasingly reported among children and young adults. The gold standard for diagnosis, usually demonstrated on endoscopie biopsies, is prominent tissue eosinophilia. However, the diagnosis may be obscured by the patchy nature of the disease, and muscular and serosal eosinophilic gastroenteritis subtypes. In the latter cases, full thickness biopsies would be indicated for a definitive diagnosis.

There are many reports of successful treatment of eosinophilic gastroenteritis in children, using a variety of treatment regimens including elimination diets. Corticosteroids remain the most effective agents for controlling symptoms, but unfortunately the relapsing nature of the disease would mandate prolonged corticosteroid use. Reports of favorable responses to new leukotriene inhibitors in patients with eosinophilic gastroenteritis are encouraging; these responses should stimulate future research on the pathophysiology and management of eosinophilic gastroenteritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II

Similar content being viewed by others

References

  1. Kaijser R. Allergic diseases of the gut from the point of view of the surgeon. Arch Klin Chir 1937; 188: 36–64

    Google Scholar 

  2. Naylor AR. Eosinophilic gastroenteritis. Scott Med J 1990; 35: 163–5

    PubMed  CAS  Google Scholar 

  3. Lee CM, Changchien CS, Chen PC, et al. Eosinophilic gastroenteritis: 10 years experience. Am J Gastroenterol 1993; 88(1): 70–4

    PubMed  CAS  Google Scholar 

  4. Goldstein NA, Putnam PE, Dohar JE. Laryngeal cleft and eosinophilic gastroenteritis: report of 2 cases. Arch Otolaryngol Head Neck Surg 2000; 126: 227–30

    PubMed  CAS  Google Scholar 

  5. Blackshaw AJ, Levison DA. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol 1986; 39: 1–7

    Article  PubMed  CAS  Google Scholar 

  6. Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 2000; 6(1): 20–7

    Article  PubMed  CAS  Google Scholar 

  7. Bischoff SC. Mucosal allergy: role of mast cells and eosinophil granulocytes in the gut. Baillieres Clin Gastroenterol 1996; 10(3): 443–59

    Article  PubMed  CAS  Google Scholar 

  8. Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001; 107: 83–90

    Article  PubMed  CAS  Google Scholar 

  9. Wattenwyl FV, Zimmermann A, Netzer P. Synchronous first manifestation of an idiopathic eosinophilic gastroenteritis and bronchial asthma. Eur J Gastroenterol Hepatol 2001; 13: 721–5

    Article  Google Scholar 

  10. Khan S, Orenstein SR. Eosinophilic gastroenteritis masquerading as pyloric stenosis. Clin Pediatr (Bologna) 2000; 39(1): 55–7

    Article  CAS  Google Scholar 

  11. Talley NJ, Shorter RG, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990; 31: 54–8

    Article  PubMed  CAS  Google Scholar 

  12. Whitington PF, Whitington GL. Eosinophilic gastroenteropathy in childhood. J Pediatr Gastroenerol Nutr 1988; 7(3): 379–85

    Article  CAS  Google Scholar 

  13. Levison DA, Blackshaw AJ. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol 1986; 39: 1–7

    Article  PubMed  Google Scholar 

  14. Horton KM, Corl FM, Fishman EK. CT of non-neoplastic diseases of the small bowel: spectrum of disease. J Comput Assist Tomogr 1999; 23(3): 417–28

    Article  PubMed  CAS  Google Scholar 

  15. Stevof C, Rao S, Parsons W, et al. EUS and histopathologic correlates in eosinophilic esophagitis. Gastrointest Endosc 2001; 54(3): 373–7

    Article  Google Scholar 

  16. Maroy B. Nonmucosal eosinophilic gastroenteritis: sonographic appearance at presentation and during follow-up of response to prednisone therapy. J Clin Ultrasound 1998; 26: 483–6

    Article  PubMed  CAS  Google Scholar 

  17. Keshavarzian A, Saverymuttu S, Tai PC, et al. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 1985; 88: 1041–9

    PubMed  CAS  Google Scholar 

  18. DeSchryver-Kecskemeti K, Clouse RE. A previously unrecognized subgroup of ‘eosinophilic gastroenteritis’: association with connective tissue disease. Am J Surg Pathol 1984; 8(3): 171–80

    Article  PubMed  CAS  Google Scholar 

  19. Koga M, Fujiwara M, Hotta N, et al. MBP deposition in eosinophilic gastroenteritis. Allergy 2000; 55: 985–6

    Article  PubMed  CAS  Google Scholar 

  20. Kelly KJ. Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 2000; 30: S28–35

    Article  PubMed  Google Scholar 

  21. Sampson HA, Anderson JA. Summary and recommendations: classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr 2000; 30: S87–94

    Article  PubMed  Google Scholar 

  22. Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spectrum of eosinophilic esophagitis in children. Am J Gastroenterol 2000; 95: 1422–30

    Article  PubMed  CAS  Google Scholar 

  23. Khan S, Orenstein SR, Di Lorenzo C, et al. Eosinophilic esophagitis: strictures, impactions, dysphagia [abstract]. Gastroenterology 2000; 118: 532

    Google Scholar 

  24. Muller MJ, Sewell GS. Coexistence of eosinophilic gastroenteritis and Helicobacter pylori gastritis: causality versus coincidence. Dig Dis Sci 2001; 46(8): 1784–6

    Article  PubMed  CAS  Google Scholar 

  25. Kalantar SJ, Lambert JR, Badov D, et al. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci 1997; 42: 2327–32

    Article  PubMed  CAS  Google Scholar 

  26. Barak N, Hart J, Sitrin MD. Enalapril-induced eosinophilic gastroenteritis. J Clin Gastroenterol 2001; 33(2): 157–8

    Article  PubMed  CAS  Google Scholar 

  27. Justinich C, Katz C, Gurbindo C, et al. Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure. J Pediatr Gastroenterol Nutr 1996; 23: 81–5

    Article  PubMed  CAS  Google Scholar 

  28. Sampson HA, Birnbaum AH. AGA technical review on the evaluation of food allergy in gastrointestinal disorders. Gastroenterology 2001; 120: 1026–40

    Article  PubMed  CAS  Google Scholar 

  29. Redondo-Cerezo E, Cabello MJ, Gonzalez Y, et al. Eosinophilic gastroenteritis, our recent experience: one-year experience of atypical onset of an uncommon disease. Scand J Gastroenterol 2000; 36: 1358–60

    Article  Google Scholar 

  30. Russel MG, Zeijen RN, Brummer RJ, et al. Eosinophilic enterocolitis diagnosed by means of technetium-99m albumin scintigraphy and treated with budesonide (CIR). Gut 1994; 35: 1490–2

    Article  PubMed  CAS  Google Scholar 

  31. Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric coated budesonide tablets. Eur J Gastroenterol Hepatol 2001; 13: 425–7

    Article  PubMed  CAS  Google Scholar 

  32. Faubion WA, Perrault J, Burgart LJ, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27: 90–3

    Article  PubMed  Google Scholar 

  33. Befus AD, Dick N, Goodacre R, et al. Mast cells from the human intestinal lamina propria. J Immunol 1987; 138: 2604–10

    PubMed  CAS  Google Scholar 

  34. Selbekk BH. The effect of disodium cromoglycate on in vitro mast cell deganulation in human jejunal mucosa. Allergy 1979; 34: 283–8

    Article  PubMed  CAS  Google Scholar 

  35. Perez-Millan A, Martin-Lorente JL, Lopez-Morante A, et al. Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci 1997; 42(2): 342–4

    Article  PubMed  CAS  Google Scholar 

  36. Gioacchino MD, Pizzicannella G, Fini N, et al. Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. Allergy 1990; 45: 161–6

    Article  PubMed  Google Scholar 

  37. Melamed I, Feanny SJ, Sherman PM, et al. Benefit of ketotifen in patients with esoinophilic gastroenteritis. Am J Med 1991; 90(3): 310–4

    Article  PubMed  CAS  Google Scholar 

  38. Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci 2001; 46(8): 1787–90

    Article  PubMed  CAS  Google Scholar 

  39. Neustrom MR, Friesen C. Treatment of eosinophilic gastroenteritis with montelukast [letter]. J Allergy Clin Immunol 1999; 104(2): 506

    Article  PubMed  CAS  Google Scholar 

  40. Shim JJ, Dabbagh K, Takeyama K, et al. Suplatast tosilate inhibits goblet cell metaplasia of airway epithelium in sensitized mice. J Allergy Clin Immunol 2000; 105: 739–45

    Article  PubMed  CAS  Google Scholar 

  41. Tamaoki J, Kondo M, Sakai N, et al. Effect of suplatast tosilate, a TH-2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomized study. Lancet 2000; 356: 273–8

    Article  PubMed  CAS  Google Scholar 

  42. Shirai T, Hashimoto D, Suzuki K, et al. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate [letter]. J Allergy Clin Immunol 2001; 107(5): 924–5

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology, Children’s Hospital of Pittsburgh, University of Pittsburgh and School of Medicine, 3705 Fifth Avenue, Pittsburgh, Pennsylvania, 15213, USA

    Seema Khan & Susan R. Orenstein

Authors
  1. Seema Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan R. Orenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seema Khan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khan, S., Orenstein, S.R. Eosinophilic Gastroenteritis. Pediatr-Drugs 4, 563–570 (2002). https://doi.org/10.2165/00128072-200204090-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128072-200204090-00002

Keywords

Search

Navigation